Vergoeding 2015-2019 voor ATC-subgroep J02AC : Triazoolderivaten
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J02AC01 Fluconazol (Diflucan ®) | 784.540 | 752.400 | 701.270 | 674.880 | 757.790 |
| J02AC02 Itraconazol (Trisporal ®) | 1.977.100 | 1.824.500 | 1.720.200 | 1.800.700 | 1.627.000 |
| J02AC03 Voriconazol (Vfend ®) | 5.840.100 | 4.552.300 | 1.201.100 | 800.370 | 655.970 |
| J02AC04 Posaconazol (Noxafil ®) | 3.930.500 | 4.535.800 | 5.235.200 | 6.118.500 | 6.759.700 |
| J02AC05 Isavuconazol (Cresemba ®) | . | . | . | 76.468 | 837.620 |
| Totaal | 12.532.240 | 11.665.000 | 8.857.770 | 9.470.918 | 10.638.080 |